---
title: "Foyou Pharma: Amlodipine Benazepril Capsules have obtained the drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255904233.md"
description: "Foyou Pharma recently obtained the drug registration certificate for Amlodipine Benazepril capsules issued by the National Medical Products Administration, approving the production of this drug. This drug is used to treat hypertension and is suitable for patients whose blood pressure cannot be satisfactorily controlled by taking Amlodipine or Benazepril alone, or as an alternative treatment"
datetime: "2025-09-04T07:39:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255904233.md)
  - [en](https://longbridge.com/en/news/255904233.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255904233.md)
---

# Foyou Pharma: Amlodipine Benazepril Capsules have obtained the drug registration certificate

According to the Zhitong Finance APP, Foyou Pharma (601089.SH) announced that it has recently received the "Drug Registration Certificate" (Certificate No.: 2025S02582) issued by the National Medical Products Administration (referred to as "NMPA") for Amlodipine Benazepril Capsules (Specification: Each capsule contains 5mg of Amlodipine Besylate (calculated as C₂₀H₂₅ClN₂O₅) and 10mg of Benazepril Hydrochloride), approving the production of this drug.

Amlodipine Benazepril Capsules were developed by Novartis and were first approved for marketing in the United States in March 1995. The original manufacturer’s Amlodipine Benazepril Capsules have not yet been marketed in China. This product is used for the treatment of hypertension, but not for initial treatment of hypertension. It is suitable for patients whose blood pressure cannot be satisfactorily controlled by taking Amlodipine or Benazepril alone; or as an alternative treatment for those taking Amlodipine tablets and Benazepril tablets simultaneously

### Related Stocks

- [601089.CN](https://longbridge.com/en/quote/601089.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [Chemtrade Logistics Holds Guidance Amid Commodity Swings](https://longbridge.com/en/news/286831060.md)
- [PRECIOUS-Gold falls more than 2% as Treasury yields, dollar weigh amid inflation concerns](https://longbridge.com/en/news/286943432.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)